Synopsis:
Ceigall India Ltd’s shares rose over 2.10 percent after securing a domestic contract by Himachal Pradesh State Industrial Development Corporation Limited (HPSIDC) worth Rs. 225 Crore
A small-cap infrastructure construction company is in the spotlight after receiving a domestic contract by the State Industrial Development Corporation Limited (HPSIDC) for the development of a Bulk Drug Park in UNA District, H.P.
With the market capitalization of Rs. 4,584.20 crore, the shares of Ceigall India Ltd is trading at Rs. 262.85, up by 0.36 percent from its previous day’s close price of Rs. 261.89 per equity share, and it has reached a high of Rs. 267.50 in the same trading day.
Work Order
Ceigall India has been awarded a domestic contract by Himachal Pradesh State Industrial Development Corporation Limited (HPSIDC) for the development of a Bulk Drug Park in UNA District, H.P.
The project (Phase I) includes SH formation cutting, internal roads, storm water drains, a bridge, and boundary fencing. It is an item-rate contract with a performance security of 3% of the contract value, to be executed over 18 months, with a total awarded cost of Rs. 225 crore.
As of June 2025, the company’s total order book stands at Rs. 10,337.4 crore, with 61.7 percent from HAM projects, 36.9 percent from EPC projects, and the remaining 1.4 percent from BOT projects.
Also Read: Alcohol stock in focus after launching PET bottle manufacturing plant in Telangana
About the Company & Others
Established in 2002, Ceigall India Limited is a prominent infrastructure construction firm with more than two decades of highway and road construction experience. It has built 1,916 lane kilometers, finished 2,159 O&M projects, and finished 35+ projects, including one HAM project. It specializes in specialized structures like flyovers, bridges, elevated roads, tunnels, highways, expressways, runways, and railway overpasses.
A return on equity (ROE) of about 20.9 percent, the return on capital employed (ROCE) of about 19.4 percent and the debt-to-equity ratio of 0.76, demonstrate the company’s financial position. At the moment, the company’s P/E ratio is 17.1x lower as compared to its industry P/E 20.8x.
In Q1FY26, the company reported revenue of Rs. 838 crore, up 1.95 percent year-on-year (YoY) from Rs. 822 crore in Q1FY25 but down 17.2 percent quarter-on-quarter (QoQ) from Rs. 1,012 crore in Q4FY25.
Profit for the quarter stood at Rs. 51 crore, declining 34.6 percent YoY from Rs. 78 crore and 29.2 percent QoQ from Rs. 72 crore, reflecting weaker margins compared to both the previous quarter and the same period last year.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
